Cargando…
Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021
We estimated vaccine effectiveness (VE) against severe COVID-19 during October 2021, using Slovenian surveillance data. For people fully vaccinated with any vaccine in age groups 18–49, 50–64, ≥ 65 years, VE was 86% (95% CI: 79–90), 89% (85–91), and 77% (74–81). Among ≥ 65 year-olds fully vaccinated...
Autores principales: | Grgič Vitek, Marta, Klavs, Irena, Učakar, Veronika, Serdt, Mojca, Mrzel, Maja, Vrh, Marjana, Fafangel, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739341/ https://www.ncbi.nlm.nih.gov/pubmed/34991780 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.1.2101110 |
Ejemplares similares
-
mRNA vaccine effectiveness against hospitalisation due to severe acute respiratory infection (SARI) COVID-19 during Omicron variant predominance estimated from real-world surveillance data, Slovenia, February to March 2022
por: Grgič Vitek, Marta, et al.
Publicado: (2022) -
Enhanced national surveillance of severe acute respiratory infections (SARI) within COVID-19 surveillance, Slovenia, weeks 13 to 37 2021
por: Klavs, Irena, et al.
Publicado: (2021) -
Estimating the annual burden of tick-borne encephalitis to inform vaccination policy, Slovenia, 2009 to 2013
por: Fafangel, Mario, et al.
Publicado: (2017) -
Letter to the editor: Applying incidence-based disability-adjusted life years (DALYs) disease burden estimates to foster change in national vaccination policy, Slovenia, 2017 to 2018
por: Fafangel, Mario, et al.
Publicado: (2018) -
The prevalence of and risk factors for healthcare-associated infections in Slovenia: results of the second national survey
por: Klavs, Irena, et al.
Publicado: (2016)